Rewalk Robotics (RWLK) Given a $3.00 Price Target at Oppenheimer

Oppenheimer set a $3.00 price objective on Rewalk Robotics (NASDAQ:RWLK) in a report released on Tuesday. The brokerage currently has a buy rating on the medical device company’s stock.

RWLK has been the topic of several other research reports. Jefferies Group decreased their price target on Rewalk Robotics from $8.00 to $5.00 and set a buy rating on the stock in a research note on Friday, November 3rd. Zacks Investment Research raised Rewalk Robotics from a hold rating to a buy rating and set a $1.50 price target on the stock in a research note on Thursday, November 9th. Finally, Canaccord Genuity reissued a buy rating and issued a $3.00 price objective on shares of Rewalk Robotics in a research note on Monday, November 6th. One analyst has rated the stock with a sell rating and four have assigned a buy rating to the stock. The company presently has an average rating of Buy and a consensus price target of $2.80.

Rewalk Robotics (RWLK) opened at $1.10 on Tuesday. The company has a quick ratio of 1.65, a current ratio of 2.02 and a debt-to-equity ratio of 7.46. The firm has a market capitalization of $31.82, a P/E ratio of -0.69 and a beta of 0.79. Rewalk Robotics has a one year low of $1.05 and a one year high of $3.60.

Rewalk Robotics (NASDAQ:RWLK) last released its quarterly earnings data on Thursday, November 2nd. The medical device company reported ($0.22) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.32) by $0.10. The business had revenue of $1.70 million for the quarter, compared to analysts’ expectations of $1.63 million. Rewalk Robotics had a negative return on equity of 568.25% and a negative net margin of 346.14%. Rewalk Robotics’s quarterly revenue was up 21.4% on a year-over-year basis. During the same period in the previous year, the business posted ($0.62) earnings per share. research analysts predict that Rewalk Robotics will post -1.14 earnings per share for the current fiscal year.

Several hedge funds have recently bought and sold shares of the company. Renaissance Technologies LLC boosted its position in Rewalk Robotics by 61.7% during the first quarter. Renaissance Technologies LLC now owns 78,600 shares of the medical device company’s stock valued at $165,000 after purchasing an additional 30,000 shares during the last quarter. Essex Investment Management Co. LLC boosted its position in Rewalk Robotics by 328.7% during the third quarter. Essex Investment Management Co. LLC now owns 156,981 shares of the medical device company’s stock valued at $228,000 after purchasing an additional 120,362 shares during the last quarter. Finally, Advisor Group Inc. boosted its position in Rewalk Robotics by 1,495.6% during the third quarter. Advisor Group Inc. now owns 181,900 shares of the medical device company’s stock valued at $264,000 after purchasing an additional 170,500 shares during the last quarter. 3.23% of the stock is owned by institutional investors.

TRADEMARK VIOLATION NOTICE: This article was first published by Community Financial News and is the property of of Community Financial News. If you are accessing this article on another publication, it was illegally stolen and republished in violation of US and international trademark and copyright legislation. The original version of this article can be viewed at https://www.com-unik.info/2017/12/27/rewalk-robotics-rwlk-given-a-3-00-price-target-at-oppenheimer.html.

Rewalk Robotics Company Profile

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.

What are top analysts saying about Rewalk Robotics? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Rewalk Robotics and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit